Betalin Therapeutics Company

Betalin Therapeutics is a privately-held company. They develop a cell therapy solution for insulin-dependent diabetes, an Engineered Micro-Pancreas (EMP). The EMP is a combination of harvested pancreatic islets (also known as Islets of Langerhans) and a proprietary biological micro-environment for supporting the harvested cells.
Technology: Biotechnology, Health Care, Wellness
Industry: Regenerative Medicine
Headquarters: Ramat Gan, Israel
Founded Date: 2015
Employees Number: 1-10
Funding Status: Early Stage Venture

Visit Website
Register and Claim Ownership